Yesterday's science-by-press-release announcement that a research team had made a "breakthrough" in treating ALS thanks to funds raised in last year's viral ice-bucket challenge turns out to be vaporware: the gene identified was already known to be implicated in ALS, but only affects 3% of cases, and the new refinement in the research suggests some avenues for further work, but has no immediate therapeutic value. (more…)